Skip to content

Doctor CHEUNG Yin Ting

Assistant Professor, School of Pharmacy,
Faculty of Medicine, CUHK

Biography

Yin Ting Cheung received her training on pharmacoepidemiology and cancer survivorship from the National University of Singapore (NUS) and St. Jude Children’s Research Hospital (Memphis, USA). Her work with the Cognitive Neuroscience Team at St. Jude involved characterizing the pharmacological, biological and genetic determinants of brain function and other treatment-related complications in survivors of childhood cancer.

Yin Ting joined the Faculty of Medicine at the Chinese University of Hong Kong in August 2017. She has initiated research/ commissioned projects for the Childhood Cancer Survivors’ Study (National Institute of Health, USA), the Chinese Children’s Cancer Group (CCCG), the Multinational Association for Supportive Care in Cancer (MASCC) and the Hospital Authority, as well as NGOs serving patients with cancer and hemophilia. She hopes that her collaborative research with students, clinicians and scientists can help to improve health outcomes in young survivors of cancer and other chronic diseases.

  • B.Sc.(Pharm) (Hons), Ph.D.

Major advances in health care delivery have dramatically improved survival rates for children, adolescents and young adults (AYAs) diagnosed with cancer and other life-threatening diseases. Unfortunately, survivorship often comes at a cost of developing a myriad of treatment-related complications that can have a negative impact on their functional outcomes and quality of life. Yin Ting’s research is focused on supportive care and survivorship in children and AYAs with cancer. Specifically, her research interests are:

  • Investigating the physiological, biobehavioral, and pharmacological factors associated late effects, particularly adverse outcomes related to brain function, such as neurocognitive impairment, neurobehavioral problems, and psychological distress.
  • Using real-world data to investigate drug utilization and subsequent health outcomes, as well as the effectiveness and safety of the use of complementary medicines in patients with cancer.
  • Developing educational resources to engage children and AYAs in taking ownership of their health.
  • Pharmacoepidemiology
  • Supportive care and cancer survivorship
  • Integrative oncology
  • The Barrie Cassilieth Memorial New Investigator Scholarship (Awarded to PhD. student Mr Jason Lam), Society for Integrative Oncology (SIO) Annual Meeting 2022
  • Best Poster Award (Palliative and Supportive Care Category), European Society for Medical Oncology (ESMO)- Asia Congress 2022
  • Silver Medal (Allied Health/Nurses Oral Abstracts Category), Joint Annual Scientific Meeting 2022 (Hybrid Meeting) of HKPS, HKCPaed, HKPNA, & HKCPN 2022
  • Steven Grunberg Memorial Award (highest-ranking abstract; Role: Senior Author), Multinational Association for Supportive Care in Cancer (MASCC) Annual Meeting 2022
  • Outstanding Trainee Award 2018/2019, Multinational Association for Supportive Care in Cancer (MASCC) Survivorship Study Group
  • American Society of Clinical Oncology (ASCO) Meeting, Conquer Cancer Foundation Merit Award, 2013, 2015 and 2017
  • Secretariat, Multinational Association of Supportive Care in Cancer (MASCC) Consumer Engagement Committee
  • Member, Children’s Oncology Group (COG) Long-term Follow-up Guidelines Committee, Neuropsychology Late Effects Panel
  • Member, Society for Integrative Oncology
  • Member, The International Society of Paediatric Oncology (SIOP)
  • External Member, Thesis Committee, Global Child Health Master’s Program, St Jude Children’s Research Hospital
  • Member and Deputy Chairman, Hospital Authority Central Institutional Review Board (Central IRB) –Pediatrics Panel
  • Member, Registration of Pharmaceutical Products & Substances: Certification of Clinical Trial/Medicinal Test Committee, Pharmacy & Poisons Board
  • Board Member, Little Life Warriors Society (NGO)
  • Member, Hong Kong Paediatric Haematology and Oncology Study Group (HKPHOSG)
  • Editorial Board Member of the Pediatric Blood & Cancer
  • Speaker (Online Educational Series), Title: Personal Health Risks in Survivors of Childhood Cancer (3 episodes)【健康講講座系列】對「症」下藥，「知」多D、「做」好D (共三集). https://www.youtube.com/playlist?list=PLZx7_g6t_vJdaAxe6Qmoo8eMacOJhcr9v
  • Speaker (Radio/Television Program), Title: Potential Interactions between Western and Chinese Medicines in Cancer Patients (兒童癌症康復者於服用長期藥物與補充或替代藥物之間的相互作用) RTHK 香港電台《精靈一點》, 23/11/2021.
  • Press Release, Title: CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine (中大研究發現半數受訪兒童癌症康復者曾使用替代補充療法 或存在「藥療相互作用」風險). https://www.med.cuhk.edu.hk/tc/press-releases/cuhk-study-finds-half-of-childhood-cancer-survivors-used-complementary-and-alternative-medicine, 01/06/2021.
  • Speaker (Television Program), Title: The Journey of Child Diagnosed with Cancer (孩子的抗癌路). NowTV《杏林在線》 (第242集), 01/01/2021.
  • Speaker (Television Program), Title: The Safe Use of Medicine in Children (兒童藥物), NowTv 《杏林在線》 (第241集), 18/12/2021.